Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

15 resultsUpdated October 23, 2026
1

Nanomedicine as a Future Therapeutic Approach for Hepatitis C Virus

Nanomedicine 14(11) (2019)

Noura Hassan Abd Ellah; Hesham M. Tawfeek; James John; ‏Helal F. Hetta

2

Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System

Iranian Biomedical Journal 23(4) (2019)

Soheila Hekmat; Seyed Mehdi Sadat; Mohammad Mehdi Aslani; Mehdi Mahdavi; Azam Bolhassani; Fateme Asgar Halvaee; Seyed Mohammad Mahdi Ghahari; Mohammad Reza Aghasadeghi; Seyed Davar Siadat

3

In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?

World Journal of Hepatology 13(10) (2021)

Natalia Echeverría; Victoria Comas; Fabián Aldunate; Paula Perbolianachis; Pilar Moreno; Juan Cristina

4

In silico Analysis of Different Signal Peptides for the Excretory Production of Recombinant NS3-GP96 Fusion Protein in Escherichia coli

International Journal of Peptide Research and Therapeutics 25(4) (2018)

Shiva Mohammadi; Zohreh Mostafavi‐Pour; Younes Ghasemi; Mahdi Barazesh; Soudabeh Kavousi Pour; Amir Atapour; Pooneh Mokarram; Mohammad Hossein Morowvat

6

Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response

Expert Review of Vaccines 24(1) (2025)

Gabriel L. Costa; Giuseppe Andrea Sautto

7

Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine

IUBMB Life 71(10) (2019)

Mohammad Hassan Pouriayevali; Taravat Bamdad; Seyed Mehdi Sadat; Seyed Amir Sadeghi; Farzaneh Sabahi; Mehdi Mahdavi; Mohammad Reza Aghasadeghi

8

Hepatitis C virus DNA vaccines: a systematic review

Virology Journal 18(1) (2021)

Ali Shayeghpour; Roya Kianfar; Parastoo Hosseini; Mehdi Ajorloo; Sepehr Aghajanian; Mojtaba Hedayat Yaghoobi; Tayebeh Hashempour; Sayed‐Hamidreza Mozhgani

9

Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine

Pathogens 13(1) (2023)

Ashraf Abdou Tabll; Sayed Sartaj Sohrab; Ahmed A. Ali; Ana Petrovic; Sabina Steiner Srdarević; Stjepan Siber; Marija Glasnović; Robert Smolić; Martina Smolić

10

Lenalidomide acts as an adjuvant for HCV DNA vaccine

International Immunopharmacology 48 (2017)

Kiandokht Borhani; Taravat Bamdad; Tayebeh Hashempour

11

Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate

Vaccine Research 3(8) (2016)

Soheila Hekmat; MM Aslani; Mehdi Shafiee Ardestani; MR Aghasadeghi; Seyed Davar Siadat; SM Sadat; Mehdi Mahdavi; Shahla Shahbazi; F Asgarhalvaee; Seyed Mohammad Mahdi Ghahari; F Tohidi

12

Development of polyepitopic immunogenic contrast against hepatitis C virus 1a-6a genotype by in silico approach

Biomedical and Biotechnology Research Journal (BBRJ) 4(4) (2020)

Fatemeh Yarian; Zeinab Dehghan; Arezu Lari; Shahrzad Ahangarzadeh; Zarin Sharifnia; Kiana Shahzamani; Solmaz Shahidi

13

A concise review on impacts of microRNAs in biology and medicine of hepatitis C virus

Gene Reports 20 (2020)

Mohammad Moradi; Farzad Mozafari; Shirin Hosseini; Rouhullah Rafiee; Faezeh Ghasemi

14

Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate

Vaccine Research 2(5) (2015)

Foozieh Javadi; Pooneh Rahimi; M H Modaressi; Mehdi Shafiee Ardestani; Azam Bolhassani; MR Aghasadeghi; SM Sadat